Market overview
The global micro balloon catheter market is worth USD 554 mn in 2026 and is forecast to reach USD 1.0 bn by 2036, growing at a 6.2% CAGR. United States is the largest country market and Coronary is the largest by application segment.
| Scope | Small-diameter balloon catheters for coronary, neurovascular and peripheral lesions, typically under 1.5 mm profile, used to cross and dilate tight lesions. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 520 mn |
| Value 2026 | USD 554 mn |
| Value 2036 | USD 1.0 bn |
| CAGR 2026-2036 | 6.2% |
| Volume 2026 | 1.16 million units |
| Volume 2036 | 1.92 million units |
| Average price 2026 | USD 478 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Micro Balloon Catheter market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 554 mn |
| 2027 | USD 588 mn |
| 2028 | USD 625 mn |
| 2029 | USD 663 mn |
| 2030 | USD 704 mn |
| 2031 | USD 748 mn |
| 2032 | USD 795 mn |
| 2033 | USD 844 mn |
| 2034 | USD 896 mn |
| 2035 | USD 952 mn |
| 2036 | USD 1.0 bn |
Micro Balloon Catheter market segmentation
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Coronary | 52.0% | 48.0% | USD 288 mn | 5.3% |
| Neurovascular | 22.0% | 25.7% | USD 122 mn | 7.8% |
| Peripheral below-the-knee | 26.0% | 26.4% | USD 144 mn | 6.3% |
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Semi-compliant | 48.0% | 43.3% | USD 266 mn | 5.1% |
| Non-compliant | 36.0% | 35.7% | USD 199 mn | 6.1% |
| Drug-coated | 16.0% | 21.0% | USD 89 mn | 9.1% |
By balloon type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Semi-compliant | 34.0% | 32.0% | USD 188 mn | 5.6% |
| Non-compliant | 30.0% | 30.0% | USD 166 mn | 6.2% |
| Drug-coated | 20.0% | 25.0% | USD 111 mn | 8.6% |
| Cutting and scoring | 16.0% | 13.0% | USD 89 mn | 4.0% |
By catheter system
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Over-the-wire | 46.0% | 43.0% | USD 255 mn | 5.5% |
| Rapid exchange | 36.0% | 38.0% | USD 199 mn | 6.8% |
| Monorail variants | 18.0% | 19.0% | USD 100 mn | 6.8% |
By diameter
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Under 1.5 mm | 38.0% | 36.0% | USD 210 mn | 5.6% |
| 1.5 to 2.5 mm | 42.0% | 42.0% | USD 233 mn | 6.2% |
| Above 2.5 mm | 20.0% | 22.0% | USD 111 mn | 7.2% |
Top 25 countries for micro balloon catheter by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 155 mn | 28.0% | USD 263 mn | 5.4% |
| 2 | Japan | USD 78 mn | 14.0% | USD 125 mn | 4.9% |
| 3 | China | USD 66 mn | 12.0% | USD 164 mn | 9.4% |
| 4 | Germany | USD 44 mn | 8.0% | USD 75 mn | 5.4% |
| 5 | France | USD 28 mn | 5.0% | USD 46 mn | 5.3% |
| 6 | Italy | USD 22 mn | 4.0% | USD 37 mn | 5.4% |
| 7 | United Kingdom | USD 22 mn | 4.0% | USD 37 mn | 5.4% |
| 8 | India | USD 17 mn | 3.0% | USD 42 mn | 9.8% |
| 9 | South Korea | USD 17 mn | 3.0% | USD 31 mn | 6.5% |
| 10 | Spain | USD 17 mn | 3.0% | USD 28 mn | 5.5% |
| 11 | Canada | USD 13 mn | 2.3% | USD 23 mn | 6.1% |
| 12 | Australia | USD 10 mn | 1.9% | USD 19 mn | 6.1% |
| 13 | Netherlands | USD 8.9 mn | 1.6% | USD 16 mn | 6.1% |
| 14 | Brazil | USD 6.9 mn | 1.2% | USD 12 mn | 6.1% |
| 15 | Turkey | USD 5.3 mn | 0.9% | USD 9.6 mn | 6.2% |
| 16 | Poland | USD 4.2 mn | 0.8% | USD 7.7 mn | 6.2% |
| 17 | Taiwan | USD 3.7 mn | 0.7% | USD 6.7 mn | 6.2% |
| 18 | Switzerland | USD 2.8 mn | 0.5% | USD 5.0 mn | 6.0% |
| 19 | Belgium | USD 2.3 mn | 0.4% | USD 4.2 mn | 6.2% |
| 20 | Mexico | USD 1.8 mn | 0.3% | USD 3.2 mn | 5.9% |
| 21 | Russia | USD 1.4 mn | 0.2% | USD 2.5 mn | 6.2% |
| 22 | Sweden | USD 1.1 mn | 0.2% | USD 2.0 mn | 6.2% |
| 23 | Thailand | USD 0.89 mn | 0.2% | USD 1.6 mn | 6.2% |
| 24 | Austria | USD 0.72 mn | 0.1% | USD 1.3 mn | 6.2% |
| 25 | Israel | USD 0.61 mn | 0.1% | USD 1.1 mn | 6.2% |
| Rest of world | USD 25 mn | 4.5% | USD 45 mn | 6.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Boston Scientific
- Terumo
- Medtronic
- Abbott
Group 2: Regional and specialist players
- Asahi Intecc
- Biotronik
- B. Braun
- Kaneka
- Cordis
- OrbusNeich
- Meril
- Nipro
- Merit Medical
Group 3: Emerging and niche players
- Balton
- Lepu Medical
- Sahajanand Medical Technologies
- Translumina
- iVascular
- Alvimedica
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the micro balloon catheter market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.2% is calculated from the resulting values.
The market is divided by application, by material, by balloon type, by catheter system, by diameter. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the micro balloon catheter market?
The global micro balloon catheter market is estimated at USD 520 mn in 2025 and USD 554 mn in 2026.
How fast will the micro balloon catheter market grow?
It is forecast to reach USD 1.0 bn by 2036, a compound annual growth rate of 6.2% from 2026, an increase of USD 457 mn.
Which country is the largest market for micro balloon catheter?
United States is the largest market by revenue at USD 155 mn in 2026, 28.0% of the global total. The three largest countries together hold 54.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.8% a year from 2026 to 2036.
Which micro balloon catheter segment is largest?
In the by application split, Coronary is the largest segment with 52.0% of 2026 revenue.
Who are the leading micro balloon catheter companies?
Global leaders include Boston Scientific, Terumo, Medtronic, Abbott.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Cancer Survivorship NutritionUSD 554 mn · 6.5% CAGR
- Shelf-Stable Clinical MealUSD 551 mn · 6.5% CAGR
- Widefield Imaging SystemsUSD 551 mn · 6.5% CAGR
- Wound Irrigation SystemsUSD 551 mn · 5.8% CAGR
- Continuous Flow BioreactorsUSD 549 mn · 11.0% CAGR
- Reproductive Toxicity StudiesUSD 549 mn · 5.3% CAGR
- Capsule Endoscope and WorkstationsUSD 562 mn · 7.5% CAGR
- Pharmaceutical Omega-3 APIUSD 546 mn · 5.5% CAGR